Babson Diagnostics raises $31M to pursue 'holy grail of diagnostics'

Babson Diagnostics CEO David Stein is leading the Austin-based medical technology company toward "the holy grail of diagnostics": being able to conduct full panels of the most frequently ordered blood tests from small volumes of blood easily collected from a fingertip. It just raised $31 million the help it commercialize the technology. Click through for more details.